Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by Snowballgrowthon Oct 09, 2021 7:55am
141 Views
Post# 33991528

RE:RE:Very good point ... it doesn't stops ...

RE:RE:Very good point ... it doesn't stops ...
Chianchin wrote: Mr J G, originaly built a great company with a a position of nearly billion dollar in cash and then recklesly and naively  of LATAM spent  most of it  $$ in LATAM where inflation and crooks are rampant and outsmart any outsiders. As well old drugs that cannot compete with new ones. No different than an old car.  Now the billion dollar is worth 20%. GBT vendors and most person who get a windfall of cash in LATAM in 24 hours move all of their $$ in the USA. It is not that complicated to understand. If GUD partenered with a dozen upcoming leading new drugs company 6-7 Years ago with cash at hand now the share price would be atleast $20 as it should.
The opportunity were plainty but G never took it to actions. Mugs and halias brain belong in the deepest past and not the present or future and sadly Excelon  does not help as it is an old drug and over GUD over paid for it. Most of us in the near future should consider a salll cash charity for Mugsy..... but not for his aliases 


Back to square one. How much free cash flow  made by  the company for last quarter ?
<< Previous
Bullboard Posts
Next >>